Ajanta Pharma Limited has announced its schedule for upcoming Analyst and Institutional Investor Meetings. The company will participate in the Jefferies India Forum on September 16, 2026, and the PL Capital Mid & Small Cap Conference on September 28, 2026. Discussions during these meetings will be strictly based on previously published information.
Ajanta Pharma Sets Analyst & Investor Meeting Schedule
Ajanta Pharma Limited has formally communicated its calendar for engagements with the investment community, detailing a series of Analyst and Institutional Investor Meetings scheduled for September 2026. These meetings are part of the company’s ongoing efforts to maintain transparent communication and provide updates to its stakeholders.
Upcoming Engagements
The schedule includes participation in the prestigious Jefferies India Forum, slated for September 16, 2026. Subsequently, Ajanta Pharma will attend the PL Capital Mid & Small Cap Conference on September 28, 2026. These events offer platforms for in-depth discussions and engagement with key financial analysts and institutional investors.
Meeting Details
The company has specified the nature of the meetings. The Jefferies India Forum event will be a one-on-one interaction, taking place at the Oberoi, New Delhi. The PL Capital Mid & Small Cap Conference will be held at Trident, BKC.
Commitment to Transparency
Ajanta Pharma has reaffirmed its commitment to adhering to disclosure norms. It has confirmed that all discussions during these meetings will be exclusively based on information that has already been made public. The company also noted that the schedule is subject to potential changes due to unforeseen circumstances.
Source: BSE
